Skip to main content
Texas Health and Human Services

An official Texas Health and Human Services website.

Here’s how you know.

Dot gov

Official websites use the Texas HHS logo.
The Texas HHS logo means this is an official website of Texas Health and Human Services.

HTTPS

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Vendor Drug Program
    • About the Program
    • Manuals
    • Contact Us
    • News
    • Policy
    • Providers
    • Pharmacy Search
    • Prescriber Search
    • 340B Providers
    • Formulary
    • Formulary Search
    • Clinician-Administered Drugs
    • Clinical Prior Authorizations for Managed Care
    • Clinical Prior Authorizations for Traditional Medicaid
    • Hepatitis C
    • Preferred Drugs
    • Prior Authorization
    • Respiratory Syncytial Virus Treatment
    • Shortages
    • Specialty Drugs
    • Drug Utilization Review Board
    • DUR Board Annual Disclosures
    • DUR Board Documents
    • DUR Board Members
    • Resources
    • Data Files
    • Documents
    • Forms
    • Managed Care
    • Manuals
    • Manufacturer Resources
    • MCO Search
    • Outreach and Education
    • Portals
    • Reports

Breadcrumb

  1. Home
  2. About
  3. Manuals
  4. Retrospective Drug Use Criteria Handbook
  5. 2. Contact
    • Search this manual
    • 1. About
    • 2. Contact
    • 3. Drug Use Compendia
    • 4. Drug Use Criteria
      • Acetylcholinesterase Inhibitors
        • Acetylcholinesterase Inhibitors - Index
        • 1. Dosage
          • 1.1. Adults
            • 1.1.1. Renal Impairment
          • 1.2. Pediatrics
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Aerosolized Agents - metered-dose inhalers: anti-cholinergic drugs
        • Aerosolized Agents - metered-dose inhalers: anti-cholinergic drugs - Index
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Aerosolized Agents - metered-dose inhalers: anti-inflammatory drugs
        • Aerosolized Agents - metered-dose inhalers: anti-inflammatory drugs - Index
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Aerosolized Agents - metered-dose inhalers: beta2 adrenergic drugs (long-acting)
        • Aerosolized Agents - metered-dose inhalers: beta2 adrenergic drugs (long-acting) - Index
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Aerosolized Agents - metered-dose inhalers: beta2 adrenergic drugs (short-acting)
        • Aerosolized Agents - metered-dose inhalers: beta2 adrenergic drugs (short-acting) - Index
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Angiotensin II Receptor Blockers
        • Angiotensin II Receptor Blockers - Index
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
          • Table 4: ARB Drug-Drug Interactions
        • 5. References
      • Angiotensin-Converting Enzyme Inhibitors
        • Angiotensin II Receptor Blockers - Index
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
            • Table 3: Pediatric Maximum Recommended Dosages for ACE inhibitors in Hypertension
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
          • Table 4: ACE Inhibitor Drug-Drug Interactions
        • 5. References
      • Anti-depressants, oral (other)
        • Anti-depressants, oral (other) - Index
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
          • 1.3. Renal Impairment
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Anti-depressants, selective serotonin reuptake inhibitors
        • Anti-depressants, selective serotonin reuptake inhibitors - Index
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
          • 1.3. Renal Impairment
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Anti-diabetic Agents (oral)
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Renal Impairment
        • 3. Duration of Therapy
        • 4. Duplicative Therapy
        • 5. Drug-Drug Interactions
        • 6. References
      • Attention Deficit Disorder/Attention Deficit Hyperactivity Disorder Medications
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Atypical Anti-psychotics (long-acting injectable)
        • Atypical Anti-psychotics (long-acting injectable) - Index
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
          • Table 6: Select LAI Atypical Antipsychotic Drug-Drug Interactions
        • 5. References
      • Atypical Anti-psychotics (oral)
        • Atypical Anti-psychotics (oral) - Index
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Benzodiazepines (Oral, Nasal, Rectal)
        • Benzodiazepines (Oral, Nasal, Rectal) - Index
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Complement Inhibitor and Enzyme/Protein Replacement Therapy
        • Complement Inhibitor and Enzyme/Protein Replacement Therapy - Index
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. References
      • Cyclooxygenase-2 Inhibitors
        • Cyclooxygenase-2 Inhibitors - Index
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
          • 1.3. Hepatic Impairment
          • 1.4 Renal Impairment
          • 1.5 Poor Metabolizers of CYP2C9 Substrates
        • 2. Duration of Therapy
          • 2.1. Therapy Limits
          • 2.2. COX-2 Inhibitor Use in Elderly Patients
          • 2.3. Selective NSAID Use and Cardiovascular Risk
          • 2.4. Selective NSAID use and Gastrointestinal Risk
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Direct Oral Anticoagulants
        • Direct Oral Anticoagulants - Index
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Exogenous Insulin Products
        • Exogenous Insulin Products - Index
        • 1. Dosage
          • 1.1. Background
          • 1.2. Adults
          • 1.3. Pediatrics
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Fentanyl
        • Fentanyl (Index)
        • 1. Fentanyl (Dosage)
        • 2. Fentanyl (Duration of Therapy)
        • 3. Fentanyl (Duplicative Therapy)
        • 4. Fentanyl (Drug-Drug Interactions)
        • 5. Fentanyl (References)
      • Fluoroquinolones (oral)
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Gabapentin
        • Gabapentin (Index)
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
          • 1.3. Renal Impairment
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Glucagon-like Peptide 1 Receptor Agonists
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Hepatitis C Direct-Acting Antivirals
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Histamine H2 - Receptor Antagonists
        • Histamine H2 - Receptor Antagonists - Index
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
          • 1.3. Dosage in Renal Impairment
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Hydrocodone Bitartrate/Hydrocodone Polistirex
        • Hydrocodone Bitartrate/Hydrocodone Polistirex (Index)
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
          • 1.3. Opioid Reversal Agents
        • 2. Duration of Therapy
        • 3. Drug-Drug Interactions
        • 4. References
      • Hydroxy-Methylglutaryl Coenzyme A Reductase Inhibitors
        • Hydroxy-Methylglutaryl Coenzyme A Reductase Inhibitors - Index
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Immune Globulins
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Ivacaftor (Kalydeco) and Lumacaftor/Ivacaftor (Orkambi)
        • Ivacaftor (Kalydeco) and Lumacaftor/Ivacaftor (Orkambi) - Index
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
          • 1.3. Dosing in Renal Impairment
          • 1.4. Dosing in Hepatic Impairment
        • 2. Duration of Therapy
        • 3. Drug-Drug Interactions
        • 4. References
      • Ketorolac (oral)
        • Ketorolac (oral) - Index
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Duration of Therapy
          • 2.1. Therapy Limits
          • 2.2. NSAID Use and Elderly Patients
          • 2.3. NSAID Use and Cardiovascular Risk
          • 2.4. NSAID use and Gastrointestinal Risk
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Leukotriene Receptor Antagonists
        • Leukotriene Receptor Antagonists - Index
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Low-Molecular-Weight Heparins
        • Low-Molecular-Weight Heparins - Index
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Duration of Therapy
          • 2.1. Adults
          • 2.2. Pediatrics
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Mecasermin
        • Mecasermin - Index
        • 1. Dosage
          • 1.1. Pediatrics
        • 2. Duration of Therapy
        • 3. References
      • Memantine
        • Memantine - Index
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Nebulized Bronchodilators
        • Nebulized Bronchodilators - Index
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Nitazoxanide (Alinia)
        • Nitazoxanide (Alinia) - Index
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Non-sedating Antihistamines
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Non-steroidal anti-inflammatory drugs
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Duration of Therapy
          • 2.1. Therapy Limits
          • 2.2. NSAID Use in Elderly Patients
          • 2.3. NSAID Use and Cardiovascular Risk
          • 2.4. NSAID Use and Gastrointestinal Risk
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Platelet Aggregation Inhibitors
        • Platelet Aggregation Inhibitors - Index
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Pramlintide
        • 1. Dosage
        • 2. Duration of Therapy
        • 3. Drug-Drug Interactions
        • 4. References
      • Promethazine Use In Children Less Than 2 Years of Age
        • Promethazine Use In Children Less Than 2 Years of Age - Index
        • 1. Dosage
          • 1.1. Pediatrics
        • 2. References
      • Proton Pump Inhibitors
        • Proton Pump Inhibitors - Index
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
          • 1.3. Dosage in Renal Impairment
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Quetiapine (low dose)
        • Quetiapine (low dose) - Index
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Duration of Therapy
        • 3. Drug-Drug Interactions
        • 4. References
      • Rifaximin (Xifaxan)
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Sedative/Hypnotics
        • Sedative/Hypnotics - Index
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Serotonin 5-HT1B/1D Receptor Agonists
        • Serotonin 5-HT1B/1D Receptor Agonists - Index
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Serotonin 5-HT3 Receptor Antagonists for Nausea and Vomiting (oral)
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Sickle Cell Disease Products
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Skeletal Muscle Relaxants
        • 1. Dosage
          • 1.1. Adults
            • 1.1.1. Dosing in Renal and Hepatic Disease
          • 1.2. Pediatrics
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Substance P/Neurokinin1 Receptor Antagonists
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
      • Topical Calcineurin Inhibitors
        • Topical Calcineurin Inhibitors - Index
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. References
      • Tramadol
        • Tramadol - Index
        • 1. Dosage
          • 1.1. Adults
          • 1.2. Pediatrics
        • 2. Duration of Therapy
        • 3. Duplicative Therapy
        • 4. Drug-Drug Interactions
        • 5. References
    • 5. Revision History

2. Contact

  • Printer-friendly version

Mailing Address

Texas Vendor Drug Program (MC-2250)

Attention: Drug Use Criteria

Texas Health and Human Services

701 W. 51st St.

Austin, TX 78751

Email

vdp-formulary@hhsc.state.tx.us

  • Texas.gov
  • Website Policy
  • Notice of Privacy Practices
  • Accessibility
  • Statewide Search
  • File-Viewing Information
  • Homeland Security
  • Compact with Texans
  • Contact Us
  • Report Fraud, Waste and Abuse

© Copyright 2018-2024. Texas Health & Human Services Commission. All rights reserved.

Back to top